Autoimmune Life Blog

In clinical trials, not all individuals respond in the same way to particular immunological therapies.

Researchers have found at the time of diagnosis with type 1 diabetes that many people continue to produce small amounts of insulin.

Scientists at BRI recently received a $2.2 million grant from the National Institutes of Health to find a unique biomarker that initiates and drives allergies.

A labor of love to honor a much loved man provides funds for type 1 diabetes research at Benaroya Research Institute at Virginia Mason (BRI). The annual David J. Fanning Memorial Golf Tournament has raised nearly $200,000 since its inception in 2011.

BRI Associate Investigator Adam Lacy-Hulbert, PhD, and his team of researchers, including Affiliate Investigator Lynda Stuart, MD, PhD, recently joined BRI. They bring new expertise in Inflamatory Bowel Disease (IBD) and the basic functioning of the immune system. Dr.

Researchers at BRI have used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA).

Near the end of her second pregnancy, Katie Cleary noticed pink dots all over her legs. Her doctor said they would go away, but when they became worse after her baby was born, she went to a dermatologist. She was diagnosed with pleva, a skin disease characterized by a recurrent red rash.

Most kids take a backpack to school for their books and lunches. But since they were 4 and 7 years old, Aaron and Justin carry their backpacks everywhere. They are filled with lifesaving medications including epinephrine auto injectors and Benadryl. Aaron also carries an asthma inhaler.

The Immune Tolerance Network’s (ITN) TrialShare Clinical Trials Research Portal has won the National Academy of Sciences Data and Information Challenge. The theme of this year’s competition was “Using Data for the Public Good.”

Have you considered volunteering for a clinical research study, but were unsure if it was something you could do comfortably and confidently?